Wednesday, July 8, 2026

pharma · Ovarian Cancer · Breast Cancer · ZNTL

Zentalis Pharmaceuticals

Zentalis Pharmaceuticals trial registry — 16 ClinicalTrials.gov studies with program phase, status, and indication context.

10275 Science Center Dr, Suite 200, San Diego, California 92121, US HQ
123 Employees
Public company Type
ZNTL · NYSE Ticker
Company details
Status
Public
HQ
10275 Science Center Dr, Suite 200, San Diego, California 92121, US
Employees
123
Programs
14
Drugs
4
Patents
0
Intelligence · Clinical Trials

Zentalis Pharmaceuticals clinical trials

Registry index of 16 ClinicalTrials.gov studies linked to Zentalis Pharmaceuticals programs — each row shows trial ID, program name, phase, status, and indication.

Zentalis Pharmaceuticals trial registry — 16 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Zentalis Pharmaceuticals.

  1. Investigator's choice of Chemotherapy — Phase 3

    Clinical update
  2. azenosertib — Phase 2

    Clinical update
  3. ZN-d5 — Phase 1

    Clinical update
  4. Azenosertib — Phase 2

    Clinical update
  5. Azenosertib — Phase 2

    Clinical update
  6. Azenosertib — Phase 2

    Clinical update
  7. ZN-d5 — Phase 2

    Clinical update
  8. ZN-d5 ZN-c3 — Phase 2

    Clinical update

Trial registry

16 studies